Sean Godbout - 01 Mar 2025 Form 3 Insider Report for BIOGEN INC. (BIIB)

Role
Chief Accounting Officer
Signature
/s/ Samuel Ntonme, attorney-in-fact for Mr. Godbout
Issuer symbol
BIIB
Transactions as of
01 Mar 2025
Net transactions value
$0
Form type
3
Filing time
10 Mar 2025, 16:08:14 UTC
Next filing
03 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIIB Common Stock 310 01 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIIB Restricted Stock Unit 01 Mar 2025 Common Stock 1,552 $0.000000 Direct F1
holding BIIB Restricted Stock Unit 01 Mar 2025 Common Stock 610 $0.000000 Direct F2
holding BIIB Restricted Stock Unit 01 Mar 2025 Common Stock 53 $0.000000 Direct F3
holding BIIB Restricted Stock Unit 01 Mar 2025 Common Stock 257 $0.000000 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/06/2025.
F2 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/07/2024.
F3 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 10/02/2023.
F4 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.